Your browser doesn't support javascript.
loading
A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma.
van Brummelen, Emilie M J; Levchenko, Evgeny; Dómine, Manuel; Fennell, Dean A; Kindler, Hedy L; Viteri, Santiago; Gadgeel, Shirish; López, Pilar Garrido; Kostorov, Vladimir; Morgensztern, Daniel; Orlov, Sergey; Zauderer, Marjorie G; Vansteenkiste, Johan F; Baker-Neblett, Katherine; Vasquez, James; Wang, Xiaowei; Bellovin, David I; Schellens, Jan H M; Yan, Li; Mitrica, Ionel; DeYoung, M Phillip; Trigo, José.
Afiliação
  • van Brummelen EMJ; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Levchenko E; Petrov Research Institute of Oncology, St. Petersburg, Russian Federation.
  • Dómine M; Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.
  • Fennell DA; University of Leicester & University Hospitals of Leicester NHS Trust, Leicester, UK.
  • Kindler HL; University of Chicago Medical Center, Chicago, IL, USA.
  • Viteri S; Instituto Oncológico Rosell, Hospital Universitario Dexeus, Grupo Quironsalud, Barcelona, Spain.
  • Gadgeel S; Karmanos Cancer Institute, Detroit, MI, USA.
  • López PG; Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Kostorov V; Leningrad Regional Oncology Dispensary, St. Petersburg, Russian Federation.
  • Morgensztern D; Washington University School of Medicine, St. Louis, MO, USA.
  • Orlov S; First Pavlov State Medical University, St. Petersburg, Russian Federation.
  • Zauderer MG; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Vansteenkiste JF; Respiratory Oncology Unit, Department of Pneumology, University Hospitals KU Leuven, Leuven, Belgium.
  • Baker-Neblett K; GlaxoSmithKline, Inc., 1250 South Collegeville Road, Collegeville, PA, USA.
  • Vasquez J; GlaxoSmithKline, Inc., 1250 South Collegeville Road, Collegeville, PA, USA.
  • Wang X; GlaxoSmithKline, Inc., 1250 South Collegeville Road, Collegeville, PA, USA.
  • Bellovin DI; Five Prime Therapeutics, Inc., South San Francisco, CA, USA.
  • Schellens JHM; Utrecht University, Utrecht, The Netherlands.
  • Yan L; GlaxoSmithKline, Inc., 1250 South Collegeville Road, Collegeville, PA, USA.
  • Mitrica I; GlaxoSmithKline, Inc., 1250 South Collegeville Road, Collegeville, PA, USA.
  • DeYoung MP; GlaxoSmithKline, Inc., 1250 South Collegeville Road, Collegeville, PA, USA. maurice.p.deyoung@gsk.com.
  • Trigo J; Phase I Trials Unit, Medical Oncology Department, Hospital Universitario Virgen de la Victoria, IBIMA, Campus Universitario Teatinos, s/n 29010, Málaga, Spain. jmtrigo@seom.org.
Invest New Drugs ; 38(2): 457-467, 2020 04.
Article em En | MEDLINE | ID: mdl-31065954
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas de Fusão Oncogênica / Cisplatino / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos / Pemetrexede / Mesotelioma Maligno / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas de Fusão Oncogênica / Cisplatino / Receptor Tipo 1 de Fator de Crescimento de Fibroblastos / Pemetrexede / Mesotelioma Maligno / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article